Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.

Andrei Carvalho SpositoIkaro BrederAlexandre A S SoaresSheila T Kimura-MedorimaDaniel B MunhozRiobaldo M R CintraIsabella BonilhaDaniela C OliveiraJessica Cunha BrederPamela CavalcanteCamila MoreiraFilipe A MouraJose Carlos de Lima-JuniorHelison R P do CarmoJoaquim BarretoWilson NadruzLuiz Sergio F CarvalhoThiago Quinaglianull null

Published in: Cardiovascular diabetology (2021)

Dapagliflozin improved micro- and macrovascular endothelial function compared to glibenclamide, regardless of glycemic control in patients with T2DM and subclinical carotid atherosclerotic disease.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
clinical trial
adipose tissue
double blind
wound healing